247 related articles for article (PubMed ID: 22953430)
21. [Tumor-induced rickets/osteomalacia].
Fukumoto S
Nihon Rinsho; 2005 Oct; 63 Suppl 10():523-8. PubMed ID: 16279694
[No Abstract] [Full Text] [Related]
22. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
23. Burosumab in tumor-induced osteomalacia: A case report.
Day AL; Gutiérrez OM; Guthrie BL; Saag KG
Joint Bone Spine; 2020 Jan; 87(1):81-83. PubMed ID: 31382017
[TBL] [Abstract][Full Text] [Related]
24. Tumor-induced Osteomalacia Caused by a Parotid Tumor.
Takashi Y; Kinoshita Y; Ito N; Taguchi M; Takahashi M; Egami N; Tajima S; Nangaku M; Fukumoto S
Intern Med; 2017; 56(5):535-539. PubMed ID: 28250301
[TBL] [Abstract][Full Text] [Related]
25. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
[TBL] [Abstract][Full Text] [Related]
26. Tumor-induced osteomalacia: The tumor may stay hidden!
van der Rest C; Cavalier E; Kaux JF; Krzesinski JM; Hustinx R; Reginster JY; Delanaye P
Clin Biochem; 2011 Oct; 44(14-15):1264-6. PubMed ID: 21843522
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced osteomalacia: a case report.
Aligail K; Dave JA; Ross IL
J Med Case Rep; 2022 Jan; 16(1):22. PubMed ID: 35016725
[TBL] [Abstract][Full Text] [Related]
28. Tumor-induced osteomalacia originating from the temporal bone: a case report.
Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
[TBL] [Abstract][Full Text] [Related]
29. Tumor-induced osteomalacia.
Jan de Beur SM
JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
[TBL] [Abstract][Full Text] [Related]
30. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case.
Dupond JL; Mahammedi H; Prié D; Collin F; Gil H; Blagosklonov O; Ricbourg B; Meaux-Ruault N; Kantelip B
Bone; 2005 Mar; 36(3):375-8. PubMed ID: 15777669
[TBL] [Abstract][Full Text] [Related]
32. Tumor-induced osteomalacia (TIO): atypical presentation.
Khaliq W; Cheripalli P; Tangella K
South Med J; 2011 May; 104(5):348-50. PubMed ID: 21606715
[TBL] [Abstract][Full Text] [Related]
33. FGF23 and disorders of phosphate homeostasis.
Yu X; White KE
Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
[TBL] [Abstract][Full Text] [Related]
34. [Rickets/Osteomalacia. Diagnosis of tumor-induced osteomalacia.].
Koga M; Ito N
Clin Calcium; 2018; 28(10):1351-1357. PubMed ID: 30269117
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
[TBL] [Abstract][Full Text] [Related]
36. [FGF23 tumor induced osteomalacia].
Gronskaia SA; Belaya ZE; Melnichenko GA
Probl Endokrinol (Mosk); 2022 Jul; 68(5):56-66. PubMed ID: 36337019
[TBL] [Abstract][Full Text] [Related]
37. Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome.
Colangelo L; Sonato C; Cipriani C; Pepe J; Farinacci G; Palmisano B; Occhiuto M; Riminucci M; Corsi A; Minisola S
Arch Osteoporos; 2023 Jul; 18(1):94. PubMed ID: 37436671
[TBL] [Abstract][Full Text] [Related]
38. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
39. Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: cure after bilateral adrenalectomy.
Ramon I; Kleynen P; Valsamis J; Body JJ; Karmali R
Calcif Tissue Int; 2011 Dec; 89(6):442-5. PubMed ID: 21910004
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]